{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T06:00:13Z","timestamp":1792476013603,"version":"4.5.0"},"reference-count":36,"publisher":"Oxford University Press (OUP)","license":[{"start":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T00:00:00Z","timestamp":1783728000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background and Aims<\/jats:title>\n                    <jats:p>Influenza infection triggers cardiovascular events, and vaccination confers cardiovascular benefit in high-risk populations. Its role in preventing incident atrial fibrillation (AF) and cardiovascular outcomes in clinical practice remains uncertain. These associations were evaluated using a real-world target-trial emulation framework.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A retrospective cohort study was conducted using the TriNetX Global Collaborative Federated Research Data Network including adults with a routine healthcare visit in 2022. Influenza vaccination within the preceding year defined exposure; comparators had no recorded vaccination. A 1:1 propensity score matching across 65 baseline variables was applied. Outcomes included incident AF, cardiovascular events, and mortality, with subgroup analyses by age and baseline cardiovascular disease.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>After matching, 276 888 patients (138 444 per group) were included with excellent covariate balance. During a mean follow-up of 2.7 \u00b1 0.7 years, influenza vaccination was associated with a significantly lower risk of incident AF [hazard ratio (HR) 0.80, 95% confidence interval (CI) 0.76\u20130.84; P &amp;lt; .0001]. The absolute annualized incidence of AF was 0.9% in vaccinated patients vs 1.1% in non-vaccinated patients. Vaccinated patients also had lower risks of all-cause mortality (HR 0.85, 95% CI 0.82\u20130.89), myocardial infarction (HR 0.91, 95% CI 0.86\u20130.97), incident heart failure (HR 0.92, 95% CI 0.88\u20130.96), and cardiovascular-related hospitalization (HR 0.97, 95% CI 0.95\u20130.99). Associations were directionally consistent across age and cardiovascular disease subgroups, without significant effect modification.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>In a large retrospective observational real-world cohort, influenza vaccination was associated with lower risks of incident AF and multiple cardiovascular outcomes. These findings support vaccination as a potential upstream strategy for AF prevention and highlight the need for randomized trials specifically designed to address AF-related outcomes.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/eurheartj\/ehag543","type":"journal-article","created":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T01:29:15Z","timestamp":1783733355000},"source":"Crossref","is-referenced-by-count":2,"title":["Influenza vaccination, incident atrial fibrillation, and cardiovascular outcomes"],"prefix":"10.1093","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9267-1658","authenticated-orcid":false,"given":"Laurent","family":"Fauchier","sequence":"first","affiliation":[{"name":"Department of Cardiology, Centre Hospitalier Universitaire Trousseau et Facult\u00e9 de M\u00e9decine, INSERM UMR1327 ISCHEMIA, Universit\u00e9 Fran\u00e7ois Rabelais. Avenue de la R\u00e9publique 37044 \u00a0 Tours ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mickael","family":"Guglieri","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Centre Hospitalier Universitaire Trousseau et Facult\u00e9 de M\u00e9decine, INSERM UMR1327 ISCHEMIA, Universit\u00e9 Fran\u00e7ois Rabelais. Avenue de la R\u00e9publique 37044 \u00a0 Tours ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2470-0760","authenticated-orcid":false,"given":"Thibault","family":"Lenormand","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Centre Hospitalier Universitaire Trousseau et Facult\u00e9 de M\u00e9decine, INSERM UMR1327 ISCHEMIA, Universit\u00e9 Fran\u00e7ois Rabelais. Avenue de la R\u00e9publique 37044 \u00a0 Tours ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3449-1800","authenticated-orcid":false,"given":"Arnaud","family":"Bisson","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Centre Hospitalier Universitaire Trousseau et Facult\u00e9 de M\u00e9decine, INSERM UMR1327 ISCHEMIA, Universit\u00e9 Fran\u00e7ois Rabelais. Avenue de la R\u00e9publique 37044 \u00a0 Tours ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7566-1626","authenticated-orcid":false,"given":"Gregory Y H","family":"Lip","sequence":"additional","affiliation":[{"name":"Liverpool Centre for Cardiovascular Science at University of Liverpool, Liverpool John Moores University and Liverpool Heart & Chest Hospital , Liverpool ,","place":["UK"]},{"name":"Department of Clinical Medicine, Aalborg University , Aalborg ,","place":["Denmark"]},{"name":"Department of Cardiology, Lipidology and Internal Medicine with Intensive Coronary Care Unit, Medical University of Bialystok , Bialystok ,","place":["Poland"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,7,11]]},"reference":[{"key":"2026071021291109000_ehag543-B1","doi-asserted-by":"publisher","first-page":"3518","DOI":"10.1093\/eurheartj\/ehaf384","article-title":"Vaccination as a new form of cardiovascular prevention: a European Society of Cardiology clinical consensus statement","volume":"46","author":"Heidecker","year":"2025","journal-title":"Eur Heart J"},{"key":"2026071021291109000_ehag543-B2","doi-asserted-by":"publisher","first-page":"605","DOI":"10.7326\/M20-1509","article-title":"Acute cardiovascular events associated with influenza in hospitalized adults: a cross-sectional study","volume":"173","author":"Chow","year":"2020","journal-title":"Ann Intern Med"},{"key":"2026071021291109000_ehag543-B3","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1093\/eurheartj\/ehac737","article-title":"Primary prevention of acute cardiovascular events by influenza vaccination: an observational study","volume":"44","author":"Davidson","year":"2023","journal-title":"Eur Heart J"},{"key":"2026071021291109000_ehag543-B4","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.1002\/ejhf.2945","article-title":"Influenza vaccination and cardiovascular events in patients with ischaemic heart disease and heart failure: a meta-analysis","volume":"25","author":"Modin","year":"2023","journal-title":"Eur J Heart Fail"},{"key":"2026071021291109000_ehag543-B5","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1161\/CIRCULATIONAHA.118.036788","article-title":"Influenza vaccine in heart failure","volume":"139","author":"Modin","year":"2019","journal-title":"Circulation"},{"key":"2026071021291109000_ehag543-B6","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1016\/S0140-6736(25)01485-0","article-title":"Influenza vaccination to improve outcomes for patients with acute heart failure (PANDA II): a multiregional, seasonal, hospital-based, cluster-randomised, controlled trial in China","volume":"406","author":"Anderson","year":"2025","journal-title":"Lancet"},{"key":"2026071021291109000_ehag543-B7","doi-asserted-by":"publisher","DOI":"10.1093\/eurjpc\/zwaf671","article-title":"Respiratory vaccines as cardiovascular prevention: evidence from four landmark trials","author":"Loubet","year":"14, 2025","journal-title":"Eur J Prev Cardiol"},{"key":"2026071021291109000_ehag543-B8","doi-asserted-by":"publisher","first-page":"1476","DOI":"10.1161\/CIRCULATIONAHA.121.057042","article-title":"Influenza vaccination after myocardial infarction: a randomized, double-blind, placebo-controlled, multicenter trial","volume":"144","author":"Frobert","year":"2021","journal-title":"Circulation"},{"key":"2026071021291109000_ehag543-B9","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1016\/j.hrthm.2016.01.026","article-title":"The association between influenza infection, vaccination, and atrial fibrillation: a nationwide case-control study","volume":"13","author":"Chang","year":"2016","journal-title":"Heart Rhythm"},{"key":"2026071021291109000_ehag543-B10","doi-asserted-by":"publisher","first-page":"970533","DOI":"10.3389\/fcvm.2022.970533","article-title":"Influenza vaccination is associated with a decreased risk of atrial fibrillation: a systematic review and meta-analysis","volume":"9","author":"Liu","year":"2022","journal-title":"Front Cardiovasc Med"},{"key":"2026071021291109000_ehag543-B11","doi-asserted-by":"publisher","first-page":"3314","DOI":"10.1093\/eurheartj\/ehae176","article-title":"2024 ESC guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS)","volume":"45","author":"Van Gelder","year":"2024","journal-title":"Eur Heart J"},{"key":"2026071021291109000_ehag543-B12","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1055\/a-2434-9244","article-title":"The 2024 European Society of Cardiology guidelines for diagnosis and management of atrial fibrillation: a viewpoint from a practicing clinician's perspective","volume":"124","author":"Potpara","year":"2024","journal-title":"Thromb Haemost"},{"key":"2026071021291109000_ehag543-B13","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1055\/a-2595-5575","article-title":"Patient care pathways and risk assessments in patients with atrial fibrillation: a comparison of Asian versus non-Asian cohorts","volume":"125","author":"Chang","year":"2025","journal-title":"Thromb Haemost"},{"key":"2026071021291109000_ehag543-B14","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.acvd.2024.12.003","article-title":"A clinician viewpoint on the 2024 European guidelines on the management of patients with atrial fibrillation","volume":"118","author":"Fauchier","year":"2025","journal-title":"Arch Cardiovasc Dis"},{"key":"2026071021291109000_ehag543-B15","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.jacc.2023.08.017","article-title":"2023 ACC\/AHA\/ACCP\/HRS guideline for the diagnosis and management of atrial fibrillation: a report of the American College of Cardiology\/American Heart Association Joint Committee on clinical practice guidelines","volume":"83","author":"Writing Committee Members","year":"2024","journal-title":"J Am Coll Cardiol"},{"key":"2026071021291109000_ehag543-B16","doi-asserted-by":"publisher","first-page":"e249305","DOI":"10.1001\/jamanetworkopen.2024.9305","article-title":"Comparative outcomes of Empagliflozin to Dapagliflozin in patients with heart failure","volume":"7","author":"Modzelewski","year":"2024","journal-title":"JAMA Netw Open"},{"key":"2026071021291109000_ehag543-B17","doi-asserted-by":"publisher","first-page":"102974","DOI":"10.1016\/j.eclinm.2024.102974","article-title":"Adverse events in clinically complex elderly patients with atrial fibrillation according to oral anticoagulation status","volume":"78","author":"Bucci","year":"2024","journal-title":"EClinicalMedicine"},{"key":"2026071021291109000_ehag543-B18","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1002\/ejhf.3165","article-title":"Use of natriuretic peptides and echocardiography for diagnosing heart failure","volume":"26","author":"Talha","year":"2024","journal-title":"Eur J Heart Fail"},{"key":"2026071021291109000_ehag543-B19","doi-asserted-by":"publisher","first-page":"9641","DOI":"10.1038\/s41467-025-64640-3","article-title":"Finerenone versus spironolactone in patients with chronic kidney disease and type 2 diabetes: a target trial emulation","volume":"16","author":"Wang","year":"2025","journal-title":"Nat Commun"},{"key":"2026071021291109000_ehag543-B20","doi-asserted-by":"publisher","first-page":"e014101","DOI":"10.1161\/CIRCEP.125.014101","article-title":"Impact of GLP-1 receptor agonist therapy on atrial fibrillation recurrence after catheter ablation in obese patients: a real-world data analysis","volume":"19","author":"Venier","year":"2026","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"2026071021291109000_ehag543-B21","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1055\/a-2633-0069","article-title":"Left atrial appendage closure after ablation for atrial fibrillation: a real-world propensity score-matched study","volume":"126","author":"Fauchier","year":"2026","journal-title":"Thromb Haemost"},{"key":"2026071021291109000_ehag543-B22","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1093\/ejhf\/xuag038","article-title":"Association of SGLT2 inhibitors and new-onset dementia in non-diabetic patients with heart failure","volume":"28","author":"Hacil","year":"2026","journal-title":"Eur J Heart Fail"},{"key":"2026071021291109000_ehag543-B23","author":"U. S. Department of Health Human Services"},{"key":"2026071021291109000_ehag543-B24","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1093\/eurheartj\/ehaf932","article-title":"Weekly journal scan: time to consider influenza vaccination as part of routine heart failure care?","volume":"47","author":"Pedicino","year":"2026","journal-title":"Eur Heart J"},{"key":"2026071021291109000_ehag543-B25","doi-asserted-by":"publisher","DOI":"10.1093\/eurjpc\/zwaf366","article-title":"Vaccination in patients with heart failure in practice","author":"Roubille","year":"25, 2025","journal-title":"Eur J Prev Cardiol"},{"key":"2026071021291109000_ehag543-B26","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.1001\/jama.2013.279206","article-title":"Association between influenza vaccination and cardiovascular outcomes in high-risk patients: a meta-analysis","volume":"310","author":"Udell","year":"2013","journal-title":"JAMA"},{"key":"2026071021291109000_ehag543-B27","doi-asserted-by":"publisher","first-page":"e228873","DOI":"10.1001\/jamanetworkopen.2022.8873","article-title":"Association of influenza vaccination with cardiovascular risk: a meta-analysis","volume":"5","author":"Behrouzi","year":"2022","journal-title":"JAMA Netw Open"},{"key":"2026071021291109000_ehag543-B28","doi-asserted-by":"publisher","first-page":"2349","DOI":"10.1016\/j.jacc.2022.03.379","article-title":"Inflammasome signaling in atrial fibrillation: JACC state-of-the-art review","volume":"79","author":"Ajoolabady","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"2026071021291109000_ehag543-B29","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1093\/eurheartj\/ehaa822","article-title":"Chronic obstructive pulmonary disease and atrial fibrillation: an interdisciplinary perspective","volume":"42","author":"Simons","year":"2021","journal-title":"Eur Heart J"},{"key":"2026071021291109000_ehag543-B30","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1016\/j.jacc.2025.07.031","article-title":"Outcomes and management of stressor-associated atrial fibrillation: JACC state-of-the-art review","volume":"86","author":"Haimovich","year":"2025","journal-title":"J Am Coll Cardiol"},{"key":"2026071021291109000_ehag543-B31","doi-asserted-by":"publisher","first-page":"2846","DOI":"10.1016\/j.jacc.2021.04.012","article-title":"Prevention of pathological atrial remodeling and atrial fibrillation: JACC state-of-the-art review","volume":"77","author":"Chen","year":"2021","journal-title":"J Am Coll Cardiol"},{"key":"2026071021291109000_ehag543-B32","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1038\/nrcardio.2015.2","article-title":"Inflammation and the pathogenesis of atrial fibrillation","volume":"12","author":"Hu","year":"2015","journal-title":"Nat Rev Cardiol"},{"key":"2026071021291109000_ehag543-B33","doi-asserted-by":"publisher","first-page":"2651","DOI":"10.1016\/j.jacc.2025.09.1578","article-title":"High-dose vs standard-dose influenza vaccine in older adults with atrial fibrillation: a prespecified analysis of the DANFLU-2 trial","volume":"86","author":"Espersen","year":"2025","journal-title":"J Am Coll Cardiol"},{"key":"2026071021291109000_ehag543-B34","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1016\/j.amepre.2019.04.007","article-title":"Seasonal influenza vaccination coverage trends among adult populations, U.S., 2010-2016","volume":"57","author":"Lu","year":"2019","journal-title":"Am J Prev Med"},{"key":"2026071021291109000_ehag543-B35","doi-asserted-by":"publisher","first-page":"100784","DOI":"10.1016\/j.lanepe.2023.100784","article-title":"Atrial fibrillation: comorbidities, lifestyle, and patient factors","volume":"37","author":"Shantsila","year":"2024","journal-title":"Lancet Reg Health Eur"},{"key":"2026071021291109000_ehag543-B36","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.acvd.2025.08.007","article-title":"Vaccination is as efficient as a cardiovascular drug! an editorial discussion of vaccination as \u201cthe new pillar in cardiovascular prevention\u201d","volume":"119","author":"Roubille","year":"2025","journal-title":"Arch Cardiovasc Dis"}],"container-title":["European Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/eurheartj\/advance-article-pdf\/doi\/10.1093\/eurheartj\/ehag543\/68757065\/ehag543.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eurheartj\/advance-article-pdf\/doi\/10.1093\/eurheartj\/ehag543\/68757065\/ehag543.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T01:29:16Z","timestamp":1783733356000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eurheartj\/advance-article\/doi\/10.1093\/eurheartj\/ehag543\/8732256"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,11]]},"references-count":36,"URL":"https:\/\/doi.org\/10.1093\/eurheartj\/ehag543","relation":{},"ISSN":["0195-668X","1522-9645"],"issn-type":[{"value":"0195-668X","type":"print"},{"value":"1522-9645","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,11]]},"article-number":"ehag543"}}